0001209191-18-050573.txt : 20180911 0001209191-18-050573.hdr.sgml : 20180911 20180911193229 ACCESSION NUMBER: 0001209191-18-050573 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180910 FILED AS OF DATE: 20180911 DATE AS OF CHANGE: 20180911 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DOYLE WILLIAM F CENTRAL INDEX KEY: 0001194459 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36517 FILM NUMBER: 181065806 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Minerva Neurosciences, Inc. CENTRAL INDEX KEY: 0001598646 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 260784194 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 286 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-600-7373 MAIL ADDRESS: STREET 1: 1601 TRAPELO ROAD STREET 2: SUITE 286 CITY: WALTHAM STATE: MA ZIP: 02451 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-09-10 0 0001598646 Minerva Neurosciences, Inc. NERV 0001194459 DOYLE WILLIAM F C/O WFD VENTURES LLC 1500 BROADWAY, 17TH FLOOR NEW YORK NY 10036 1 0 0 0 Common Stock 2018-09-10 4 P 0 4000 9.88 A 4000 D Common Stock 2018-09-11 4 P 0 4011 9.72 A 8011 D The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.75 to $10.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (2) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.50 to $9.95, inclusive. /s/ Matt Bartholomae, Attorney-in-Fact 2018-09-11